Skip to content

Intradermal Needle of acute pain after total knee arthroplasty Clinical study

Intradermal Needle of acute pain after total knee arthroplasty Clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080816
Enrollment
Unknown
Registered
2024-02-07
Start date
2023-05-22
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Postoperative pain

Interventions

Test group:Bilateral Hegu, Zusanli, Xuanzhong, Yinlingquan and Yanglingquan acupoints were selected and intervened with intradermal needles once every other day for a total of 7 times.
control group:Bilateral Hegu, Zusanli, Xuanzhong, Yinlingquan and Yanglingquan acupoints were selected and intervened with sham acupuncture once every other day for a total of 7 times.

Sponsors

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients who meet the diagnostic criteria of unilateral knee osteoarthritis and meet the surgical indications ; 2, aged between 60 and 80 years old ; 3.All patients who signed the informed consent, were willing to accept and cooperate with the examination and treatment and postoperative follow-up.

Exclusion criteria

Exclusion criteria: 1.Patients with any drug allergy or suspected allergy in the study. 2.Patients with coagulation disorders or liver disease ; or have a history of bleeding. 3.Patients with high risk of systemic infection, hip skin damage, and poor local infection control. 4.Heparin, low molecular weight heparin, etc.have been continuously used before surgery. 5.Long-term use of central and peripheral nerve analgesics, long-term use of glucocorticoids, long-term use of non-steroidal anti-inflammatory analgesics ; the history of medication in conflict with this study. 6.Severe liver and kidney dysfunction, severe cardiovascular and cerebrovascular diseases, malignant tumors and other medical history. 7.Reluctant to cooperate with this study, or patients with mental illness, other reasons can not be included in the group.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;

Secondary

MeasureTime frame
PGE2;Stress pain threshold test;

Countries

China

Contacts

Public ContactHaibo Zhou

Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

441737502@qq.com+86 181 4661 2093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026